Akynzeo

(netupitant / palonosetron)
Akynzeo 235 MG / 0.25 MG in 20 ML InjectionAkynzeo 235 MG / 0.25 MG Injection
View 1 more
NO BLACK BOX WARNING

Dosage & administration

Recommended Dosage

Preparation and Administration


biomarker testing

Akynzeo clinical details

Genetic testing requirements were obtained from the NCCN guidelines for each cancer type.

drug label

Akynzeo prescribing information

patient education

Akynzeo patient education

Getting started on Akynzeo

BRAND PAGE
Instructions For Use - Prevention of Nausea & Vomitting during Chemotherapy
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
To share resource; ask patient to:
1.Pull out phone
2.Open camera
3.Scan QR code with camera
4.Tap link

Patient toolkit

Learn More

Other resources

Learn More

people also ask

Akynzeo FAQs

How is the dosage of Akynzeo?Akynzeo is available in 3 dosages, including 11.75-0.0125 mg/ml Injection 20 ml, 235-0.25 mg Injection and 300-0.5 mg Cap
What does Akynzeo treat?Akynzeo treats
What is Akynzeo made of?Akynzeo contains netupitant / palonosetron which is a Serotonin-3 Receptor Antagonist
How Is Akynzeo Administered?Akynzeo is administered as a Injectable or Oral Pill
What Are The Akynzeo Mechanism Of Action?Akynzeo mechanism of action is Breast Cancer Resistance Protein Inhibitors, Cytochrome P450 3A4 Inhibitors, Neurokinin 1 Antagonists, P-Glycoprotein Inhibitors or Serotonin 3 Receptor Antagonists
FAQ Data Source